Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study

IntroductionAlthough adherence to immunosuppressive medication is the key factor for long-term graft survival today, 20–70% of transplant recipients are non-adherent to their immunosuppressive medication.ObjectiveA prospective, randomized, controlled single-center feasibility study was designed to e...

Full description

Bibliographic Details
Main Authors: Jolana Wagner-Skacel, Nadja Fink, Judith Kahn, Nina Dalkner, Emanuel Jauk, Susanne Bengesser, Marco Mairinger, Gerhard Schüssler, Christoph Pieh, Vanessa Stadlbauer, Alexander H. Kirsch, Sabine Zitta, Alexander R. Rosenkranz, Peter Fickert, Peter Schemmer
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Psychology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1150548/full
_version_ 1811157794475212800
author Jolana Wagner-Skacel
Jolana Wagner-Skacel
Nadja Fink
Nadja Fink
Judith Kahn
Judith Kahn
Nina Dalkner
Emanuel Jauk
Susanne Bengesser
Marco Mairinger
Gerhard Schüssler
Christoph Pieh
Vanessa Stadlbauer
Alexander H. Kirsch
Alexander H. Kirsch
Sabine Zitta
Sabine Zitta
Alexander R. Rosenkranz
Alexander R. Rosenkranz
Peter Fickert
Peter Fickert
Peter Schemmer
Peter Schemmer
author_facet Jolana Wagner-Skacel
Jolana Wagner-Skacel
Nadja Fink
Nadja Fink
Judith Kahn
Judith Kahn
Nina Dalkner
Emanuel Jauk
Susanne Bengesser
Marco Mairinger
Gerhard Schüssler
Christoph Pieh
Vanessa Stadlbauer
Alexander H. Kirsch
Alexander H. Kirsch
Sabine Zitta
Sabine Zitta
Alexander R. Rosenkranz
Alexander R. Rosenkranz
Peter Fickert
Peter Fickert
Peter Schemmer
Peter Schemmer
author_sort Jolana Wagner-Skacel
collection DOAJ
description IntroductionAlthough adherence to immunosuppressive medication is the key factor for long-term graft survival today, 20–70% of transplant recipients are non-adherent to their immunosuppressive medication.ObjectiveA prospective, randomized, controlled single-center feasibility study was designed to evaluate the impact of a step guided multicomponent interprofessional intervention program for patients after kidney or liver transplantation on adherence to their immunosuppressive medication in daily clinical practice.Materials and methodsThe intervention consisted of group therapy and daily training as well as individual sessions in a step guided approach. The primary endpoint of the study was adherence to immunosuppression as assessed with the “Basel Assessment of Adherence to Immunosuppressive Medications Scale” (BAASIS). The coefficient of variation (CV%) of Tacrolimus (TAC) through levels and the level of personality functioning was a secondary endpoint. We conducted six monthly follow-up visits.ResultsForty-one age- and sex-matched patients [19 females, 58.5 (SD = 10.56) years old, 22 kidney- and 19 liver transplantation] were randomized to the intervention- (N = 21) or control-group (N = 20). No differences between intervention- and control groups were found in the primary endpoint adherence and CV% of TAC. However, in further exploratory analyses, we observed that individuals with higher impairments in personality functioning showed higher CV% of TAC in the controls. The intervention might compensate personality-related susceptibility to poor adherence as evident in CV% of TAC.DiscussionThe results of the feasibility study showed that this intervention program was highly accepted in the clinical setting. The Intervention group could compensate higher CV% of TAC after liver or kidney transplantation in individuals with lower levels of personality functioning and non-adherence.Clinical trial registrationClinicalTrials.gov, identifier NCT04207125.
first_indexed 2024-04-10T05:13:26Z
format Article
id doaj.art-13d80ed651674afca418c9cf29842051
institution Directory Open Access Journal
issn 1664-1078
language English
last_indexed 2024-04-10T05:13:26Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychology
spelling doaj.art-13d80ed651674afca418c9cf298420512023-03-09T05:27:23ZengFrontiers Media S.A.Frontiers in Psychology1664-10782023-03-011410.3389/fpsyg.2023.11505481150548Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility studyJolana Wagner-Skacel0Jolana Wagner-Skacel1Nadja Fink2Nadja Fink3Judith Kahn4Judith Kahn5Nina Dalkner6Emanuel Jauk7Susanne Bengesser8Marco Mairinger9Gerhard Schüssler10Christoph Pieh11Vanessa Stadlbauer12Alexander H. Kirsch13Alexander H. Kirsch14Sabine Zitta15Sabine Zitta16Alexander R. Rosenkranz17Alexander R. Rosenkranz18Peter Fickert19Peter Fickert20Peter Schemmer21Peter Schemmer22Department of Medical Psychology, Psychosomatics, and Psychotherapy, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Abdominal, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Abdominal, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, AustriaDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, AustriaDepartment of Medical Psychology, Psychosomatics, and Psychotherapy, Medical University of Graz, Graz, AustriaDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, AustriaDepartment of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, AustriaDepartment of Medical Psychology, Psychosomatics, and Psychotherapy, Medical University of Graz, Graz, AustriaDepartment of Psychosomatic Medicine, University for Continuing Education Krems, Krems an der Donau, AustriaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Nephrology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, AustriaUniversity Transplant Center Graz, Medical University of Graz, Graz, AustriaDivision of Abdominal, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, Graz, AustriaIntroductionAlthough adherence to immunosuppressive medication is the key factor for long-term graft survival today, 20–70% of transplant recipients are non-adherent to their immunosuppressive medication.ObjectiveA prospective, randomized, controlled single-center feasibility study was designed to evaluate the impact of a step guided multicomponent interprofessional intervention program for patients after kidney or liver transplantation on adherence to their immunosuppressive medication in daily clinical practice.Materials and methodsThe intervention consisted of group therapy and daily training as well as individual sessions in a step guided approach. The primary endpoint of the study was adherence to immunosuppression as assessed with the “Basel Assessment of Adherence to Immunosuppressive Medications Scale” (BAASIS). The coefficient of variation (CV%) of Tacrolimus (TAC) through levels and the level of personality functioning was a secondary endpoint. We conducted six monthly follow-up visits.ResultsForty-one age- and sex-matched patients [19 females, 58.5 (SD = 10.56) years old, 22 kidney- and 19 liver transplantation] were randomized to the intervention- (N = 21) or control-group (N = 20). No differences between intervention- and control groups were found in the primary endpoint adherence and CV% of TAC. However, in further exploratory analyses, we observed that individuals with higher impairments in personality functioning showed higher CV% of TAC in the controls. The intervention might compensate personality-related susceptibility to poor adherence as evident in CV% of TAC.DiscussionThe results of the feasibility study showed that this intervention program was highly accepted in the clinical setting. The Intervention group could compensate higher CV% of TAC after liver or kidney transplantation in individuals with lower levels of personality functioning and non-adherence.Clinical trial registrationClinicalTrials.gov, identifier NCT04207125.https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1150548/fullliver transplantationkidney transplantationadherenceimmunosuppressionmultilevel intervention
spellingShingle Jolana Wagner-Skacel
Jolana Wagner-Skacel
Nadja Fink
Nadja Fink
Judith Kahn
Judith Kahn
Nina Dalkner
Emanuel Jauk
Susanne Bengesser
Marco Mairinger
Gerhard Schüssler
Christoph Pieh
Vanessa Stadlbauer
Alexander H. Kirsch
Alexander H. Kirsch
Sabine Zitta
Sabine Zitta
Alexander R. Rosenkranz
Alexander R. Rosenkranz
Peter Fickert
Peter Fickert
Peter Schemmer
Peter Schemmer
Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
Frontiers in Psychology
liver transplantation
kidney transplantation
adherence
immunosuppression
multilevel intervention
title Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
title_full Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
title_fullStr Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
title_full_unstemmed Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
title_short Improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning – A randomized controlled single center feasibility study
title_sort improving adherence to immunosuppression after liver or kidney transplantation in individuals with impairments in personality functioning a randomized controlled single center feasibility study
topic liver transplantation
kidney transplantation
adherence
immunosuppression
multilevel intervention
url https://www.frontiersin.org/articles/10.3389/fpsyg.2023.1150548/full
work_keys_str_mv AT jolanawagnerskacel improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT jolanawagnerskacel improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT nadjafink improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT nadjafink improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT judithkahn improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT judithkahn improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT ninadalkner improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT emanueljauk improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT susannebengesser improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT marcomairinger improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT gerhardschussler improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT christophpieh improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT vanessastadlbauer improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT alexanderhkirsch improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT alexanderhkirsch improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT sabinezitta improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT sabinezitta improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT alexanderrrosenkranz improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT alexanderrrosenkranz improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT peterfickert improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT peterfickert improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT peterschemmer improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy
AT peterschemmer improvingadherencetoimmunosuppressionafterliverorkidneytransplantationinindividualswithimpairmentsinpersonalityfunctioningarandomizedcontrolledsinglecenterfeasibilitystudy